Literature DB >> 6223072

Decreased Fc receptor avidity and degradative function of monocytes from patients with systemic lupus erythematosus.

S Katayama, D Chia, D W Knutson, E V Barnett.   

Abstract

We studied the binding and degradation of stable, soluble heat aggregates of 125I-IgG (A-IgG) by monocytes from 30 patients with systemic lupus erythematosus (SLE) and 30 normals. Relative avidities (KE) for Fc receptor (FcR) binding of A-IgG and maximal binding of A-IgG by monocytes were determined from Scatchard plots of binding data obtained at 4 degrees C. Rates of degradation (Vmax) of A-IgG at 37 degrees C were calculated from Lineweaver-Burke plots of the Michaelis-Menton equation. KE were decreased in SLE monocytes (15.5 X 10(-9) L/M) as compared with normals (20.1 X 10(-9) L/M, p less than 0.005) and Vmax were decreased for SLE (0.89 ng/hr) as compared with normals (1.11 ng/hr, p less than 0.005). The maximal FcR binding by SLE monocytes was not statistically different in SLE patients and normals, but monocytes from SLE patients with active disease showed a lower maximal binding capacity for A-IgG (4.9 ng/10(5) cells) than normals (5.4 ng/10(5) cells, p less than 0.05). KE and Vmax in SLE were also lower for patients with active disease than for normal subjects. KE in patients whose anti-ssDNA binding was greater than 20% were lower than for those with DNA binding of less than 20% (p less than 0.005). These data suggest that patients with active SLE have diminished numbers of available FcR on their circulating monocytes, possibly due to interiorization of FcR during endocytosis of endogenous circulating immune complexes.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6223072

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  9 in total

1.  Prolonged circulation of immune complexes due to various altered immune functions contributes to nephritis in MRL/lpr mice.

Authors:  N A Granholm; T Cavallo
Journal:  Clin Exp Immunol       Date:  1990-11       Impact factor: 4.330

2.  Defective hepatic handling of IgA immune aggregates by mice with experimental IgA nephropathy.

Authors:  E González; J González-Cabrero; J Egido
Journal:  Immunology       Date:  1989-07       Impact factor: 7.397

3.  Endocytosis of particulate and soluble IgG immune complexes: differential effects of cytoskeletal modulating agents.

Authors:  D S Finbloom; J Martin; R K Gordon
Journal:  Clin Exp Immunol       Date:  1987-01       Impact factor: 4.330

4.  Blood clearance and tissue localization of soluble aggregates of IgG in NZB/W and NZB mice.

Authors:  D W Knutson; D Chia; E V Barnett; L Levy
Journal:  Immunology       Date:  1985-03       Impact factor: 7.397

5.  Increased production of the third component of complement (C3) by monocytes from patients with systemic lupus erythematosus.

Authors:  H Tsukamoto; A Ueda; K Nagasawa; Y Tada; Y Niho
Journal:  Clin Exp Immunol       Date:  1990-11       Impact factor: 4.330

6.  Diminished response to an inhibitory signal in lymphocytes from patients with systemic lupus erythematosus.

Authors:  M Salata; J Golbus; B C Richardson
Journal:  Clin Exp Immunol       Date:  1988-03       Impact factor: 4.330

7.  The change in C3b receptors on erythrocytes from patients with systemic lupus erythematosus.

Authors:  K Yoshida; Y Yukiyama; S Hirose; T Miyamoto
Journal:  Clin Exp Immunol       Date:  1985-06       Impact factor: 4.330

8.  Expression of Fc receptors is suppressed in alveolar macrophages from patients with sarcoidosis.

Authors:  S Hayashi; K Yagawa; M Nakanishi; K Ogata; M Maruyama; N Shigematsu
Journal:  Clin Exp Immunol       Date:  1988-09       Impact factor: 4.330

9.  Elevated levels of soluble CD14 in serum of patients with systemic lupus erythematosus.

Authors:  W A Nockher; R Wigand; W Schoeppe; J E Scherberich
Journal:  Clin Exp Immunol       Date:  1994-04       Impact factor: 4.330

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.